The therapeutic potential of human olfactory-derived stem cells.
Stem cells from fetal and adult central nervous system have been isolated and characterized, providing populations for potential replacement therapy for traumatic injury repair and neurodegenerative diseases. The regenerative capacity of the olfactory system has attracted scientific interest. Studies focusing on animal and human olfactory bulb ensheathing cells (OECs) have heightened the expectations that OECs can enhance axonal regeneration and repair demyelinating diseases. Harvest of OECs from the olfactory bulb requires highly invasive surgery, which is a major obstacle. In contrast, olfactory epithelium (OE) has a unique regenerative capacity and is readily accessible from its location in the nasal cavity, allowing for harvest without lasting damage to the donor. Adult OE contains progenitors responsible for the normal life-long continuous replacement of neurons and supporting cells. Culture techniques have been established for human OE that generate populations of mitotically active neural progenitors that form neurospheres (Roisen et al., 2001; Winstead et al., 2005). The potential application of this technology includes autologous transplantation where minimal donor material can be isolated, expanded ex vivo, and lineage restricted to a desired phenotype prior to/or after re-implantation. Furthermore, these strategies circumvent the ethical issues that arise with embryonic or fetal tissues. The long term goal is to develop procedures through which a victim of a spinal cord injury or neurodegenerative condition would serve as a source of progenitors for his/her own regenerative grafts, avoiding the need for immunosuppression and ethical controversy. In addition, these cells can provide populations for pharmacological and/or diagnostic evaluation.
Marshall
C T
CT
Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Lu
C
C
Winstead
W
W
Zhang
X
X
Xiao
M
M
Harding
G
G
Klueber
K M
KM
Roisen
F J
FJ
D002478:Cells, Cultured; D006801:Humans; D007150:Immunohistochemistry; D007381:Intermediate Filament Proteins / Q000032:analysis; D008562:Membrane Glycoproteins / Q000032:analysis; D009416:Nerve Regeneration; D009419:Nerve Tissue Proteins / Q000032:analysis; D064231:Nestin; D019636:Neurodegenerative Diseases / Q000628:therapy; D009830:Olfactory Bulb / Q000737:chemistry / Q000166:cytology* / Q000502:physiology; D009831:Olfactory Mucosa / Q000737:chemistry / Q000166:cytology / Q000502:physiology; D064531:Peripherins; D017475:Receptors, Nerve Growth Factor / Q000032:analysis; D013119:Spinal Cord Injuries / Q000628:therapy; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000737:chemistry / Q000166:cytology* / Q000502:physiology*; D014404:Tubulin / Q000032:analysis
D007381:Intermediate Filament Proteins; D008562:Membrane Glycoproteins; C577484:NES protein, human; D009419:Nerve Tissue Proteins; D064231:Nestin; D064531:Peripherins; D017475:Receptors, Nerve Growth Factor; D014404:Tubulin